Soft Tissue Sarcomas (TSS) update from diagnosis to treatment

Detalhes bibliográficos
Autor(a) principal: Freitas, M. Jorge
Data de Publicação: 2014
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://onco.news/index.php/journal/article/view/132
Resumo: Soft tissue sarcomas (STS) are rare tumors, approximately 1% of all malignant tumors worldwide, and are responsible for 2% of cancer mortality. The survival of a patient with sarcoma depends on several factors: tumor size, location, histology, mitotic rate and superficial or deep location. The STS can be classified into two different stages: those that are localized and those that disseminated to distance, defining different forms of treatment and intervention. The treatment requires the intervention of a multidisciplinary team with trained professionals in specialized centers. Current treatment options include surgery, radiotherapy and chemotherapy, according to the grade, stage of disease and the presence or absence of metastasis.
id RCAP_95aae15e5ca7648f011deab349a4262e
oai_identifier_str oai:oai.onco.news:article/132
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Soft Tissue Sarcomas (TSS) update from diagnosis to treatmentSarcomas tecidos moles (sts) update do diagnóstico ao tratamentoSarcomas dos tecidos molesSTSdisseminaçãoestadiamentotratamentoSoft tissue sarcomasSTSdisseminationstagingtreatmentSoft tissue sarcomas (STS) are rare tumors, approximately 1% of all malignant tumors worldwide, and are responsible for 2% of cancer mortality. The survival of a patient with sarcoma depends on several factors: tumor size, location, histology, mitotic rate and superficial or deep location. The STS can be classified into two different stages: those that are localized and those that disseminated to distance, defining different forms of treatment and intervention. The treatment requires the intervention of a multidisciplinary team with trained professionals in specialized centers. Current treatment options include surgery, radiotherapy and chemotherapy, according to the grade, stage of disease and the presence or absence of metastasis.Sarcomas dos tecidos moles (STS) são tumores raros, constituem cerca de 1% do total de tumores malignos a nível mundial e são responsáveis por 2% da mortalidade por cancro. A sobrevivência de um doente com sarcoma depende de muitos factores, entre eles o tamanho do tumor, a sua localização, a tipologia histológica, taxa de mitose e se está localizado superficialmente ou é profundo. Os STS podem-se classificar em dois estados diferentes: aqueles que se encontram na fase localizada e os que se encontram disseminados devido à presença de metástases à distância, defindo formas diferentes de tratamento e de intervenção. O tratamento requere a intervenção de uma equipa multidisciplinar com profissionais treinados em centros especializados. As opções actuais de tratamento incluem a cirurgia, radioterapia e quimioterapia de de acordo com o grau, o estadio da doença e a presença ou não de metástases.AEOP – Associação de Enfermagem Oncológica Portuguesa2014-07-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/132Onco.news; No. 27 (2014): Onco.News Journal; 8-16Onco.News; N.º 27 (2014): Revista Onco.News; 8-162183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/132https://onco.news/index.php/journal/article/view/132/145Direitos de Autor (c) 2023 M. Jorge Freitasinfo:eu-repo/semantics/openAccessFreitas, M. Jorge2024-03-16T07:55:21Zoai:oai.onco.news:article/132Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:23.167781Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
Sarcomas tecidos moles (sts) update do diagnóstico ao tratamento
title Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
spellingShingle Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
Freitas, M. Jorge
Sarcomas dos tecidos moles
STS
disseminação
estadiamento
tratamento
Soft tissue sarcomas
STS
dissemination
staging
treatment
title_short Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
title_full Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
title_fullStr Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
title_full_unstemmed Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
title_sort Soft Tissue Sarcomas (TSS) update from diagnosis to treatment
author Freitas, M. Jorge
author_facet Freitas, M. Jorge
author_role author
dc.contributor.author.fl_str_mv Freitas, M. Jorge
dc.subject.por.fl_str_mv Sarcomas dos tecidos moles
STS
disseminação
estadiamento
tratamento
Soft tissue sarcomas
STS
dissemination
staging
treatment
topic Sarcomas dos tecidos moles
STS
disseminação
estadiamento
tratamento
Soft tissue sarcomas
STS
dissemination
staging
treatment
description Soft tissue sarcomas (STS) are rare tumors, approximately 1% of all malignant tumors worldwide, and are responsible for 2% of cancer mortality. The survival of a patient with sarcoma depends on several factors: tumor size, location, histology, mitotic rate and superficial or deep location. The STS can be classified into two different stages: those that are localized and those that disseminated to distance, defining different forms of treatment and intervention. The treatment requires the intervention of a multidisciplinary team with trained professionals in specialized centers. Current treatment options include surgery, radiotherapy and chemotherapy, according to the grade, stage of disease and the presence or absence of metastasis.
publishDate 2014
dc.date.none.fl_str_mv 2014-07-02
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://onco.news/index.php/journal/article/view/132
url https://onco.news/index.php/journal/article/view/132
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://onco.news/index.php/journal/article/view/132
https://onco.news/index.php/journal/article/view/132/145
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2023 M. Jorge Freitas
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2023 M. Jorge Freitas
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
dc.source.none.fl_str_mv Onco.news; No. 27 (2014): Onco.News Journal; 8-16
Onco.News; N.º 27 (2014): Revista Onco.News; 8-16
2183-6914
1646-7868
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138187628511232

Registros relacionados